Kalkitoxin inhibits osteoclast formation and bone loss

被引:0
|
作者
Soh, Y. [1 ]
Sapkota, M. [1 ]
Shrestha, S. [1 ]
机构
[1] Chonbuk Natl Univ, Sch Dent, Dept Dent Pharmacol, Jeonju, South Korea
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P1815
引用
收藏
页数:2
相关论文
共 50 条
  • [21] NSAID INHIBITS OSTEOCLAST-LIKE CELLS FORMATION AND BONE-RESORPTION
    SOEKANTO, A
    JOURNAL OF DENTAL RESEARCH, 1995, 74 : 420 - 420
  • [22] miR-21 deficiency inhibits osteoclast function and prevents bone loss in mice
    Hu, Cheng-Hu
    Sui, Bing-Dong
    Du, Fang-Ying
    Shuai, Yi
    Zheng, Chen-Xi
    Zhao, Pan
    Yu, Xiao-Rui
    Jin, Yan
    SCIENTIFIC REPORTS, 2017, 7
  • [23] miR-21 deficiency inhibits osteoclast function and prevents bone loss in mice
    Cheng-Hu Hu
    Bing-Dong Sui
    Fang-Ying Du
    Yi Shuai
    Chen-Xi Zheng
    Pan Zhao
    Xiao-Rui Yu
    Yan Jin
    Scientific Reports, 7
  • [24] RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss
    Hu, Yan
    Li, Xiaoqun
    Zhi, Xin
    Cong, Wei
    Huang, Biaotong
    Chen, Huiwen
    Wang, Yajun
    Li, Yinghua
    Wang, Lipeng
    Fang, Chao
    Guo, Jiawei
    Liu, Ying
    Cui, Jin
    Cao, Liehu
    Weng, Weizong
    Zhou, Qirong
    Wang, Sicheng
    Chen, Xiao
    Su, Jiacan
    EMBO REPORTS, 2021, 22 (07)
  • [25] Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss
    Stubelius, Alexandra
    Andersson, Annica
    Holmdahl, Rikard
    Ohlsson, Claes
    Islander, Ulrika
    Carlsten, Hans
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17 : 1 - 7
  • [26] Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation
    Lean, JM
    Jagger, CJ
    Kirstein, B
    Fuller, K
    Chambers, TJ
    ENDOCRINOLOGY, 2005, 146 (02) : 728 - 735
  • [27] Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss
    Alexandra Stubelius
    Annica Andersson
    Rikard Holmdahl
    Claes Ohlsson
    Ulrika Islander
    Hans Carlsten
    BMC Musculoskeletal Disorders, 17
  • [28] Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo
    Sun, Peng
    Yang, Qichang
    Wang, Yanben
    Peng, Jiaxuan
    Zhao, Kangxian
    Jia, Yewei
    Zhang, Tan
    Lu, Xuanyuan
    Han, Weiqi
    Qian, Yu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 4189 - 4203
  • [29] Salazosulfapyridine inhibits osteoclast-like cell formation and bone resorption in vitro.
    Tajiri, Y
    Tanaka, S
    Oda, H
    Takayanagi, H
    Nakamura, K
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S207 - S207
  • [30] PD-1 blockade inhibits osteoclast formation and murine bone cancer pain
    Wang, Kaiyuan
    Gu, Yun
    Liao, Yihan
    Bang, Sangsu
    Donnelly, Christopher R.
    Chen, Ouyang
    Tao, Xueshu
    Mirando, Anthony J.
    Hilton, Matthew J.
    Ji, Ru-Rong
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (07): : 3603 - 3620